A Shared Decision-making Training for Inpatients With Schizophrenia

Schizophrenia Clinical Trial

Official title:

A Shared Decision-making Training for Inpatients With Schizophrenia

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02349880
• Other study ID #: SDM-training
• Status: Completed
• Phase: N/A
• First received: January 23, 2015
• Last updated: April 24, 2018
• Start date: October 2011
• Est. completion date: March 2015

Study information

• Verified date: April 2018
• Source: Technische Universität München
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

"Shared decision-making" is being promoted as a promising approach for engaging patients with schizophrenia in medical decisions and improving satisfaction and adherence.

To implement shared decision-making, both physicians and patients should commit to it and engage in a mutual decision process. Most research, however, has addressed interventions that either focus on the doctors' side (e.g. "communication skills") or on informing patients about treatment options (e.g. "decision aids"). These approaches have been shown to be feasible in clinical practice but had no strong effects on treatment patterns or adherence, possibly because they were insufficient to motivate and enable patients to engage actively in decision-making. Moreover, these interventions still rely on the doctor's willingness to share decisions, which has been shown to vary considerably.

To overcome these limitations and since many patients do not feel competent to participate in decision-making we developed an intervention that focuses on patients' communicative competencies. this intervention, a five session group-training, will be implemented for inpatients suffering from schizophrenia.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 264
• Est. completion date: March 2015
• Est. primary completion date: December 2014
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• age 18-65

• icd diagnosis F2

• sufficient German language skills

Exclusion Criteria:

• debility

Related Conditions & MeSH terms

• Mood Disorders
• Psychotic Disorders
• Schizo-affective Disorder
• Schizophrenia

Intervention

Behavioral:
• shared decision making training

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Technische Universität München

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	adherence to antipsychotic medication		12 months